Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Application area of Genomics and Increasing Government Funding
4.2.2 Declining Sequencing Cost
4.3 Market Restraints
4.3.1 High Cost of Equipment
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product & Services
5.1.1 Consumables
5.1.2 Systems & Software
5.1.3 Services
5.2 By Techniques
5.2.1 PCR
5.2.2 Sequencing
5.2.3 Microarray
5.2.4 Nucleic Acid Extraction and Purification
5.2.5 Others
5.3 By Application
5.3.1 Diagnostics
5.3.2 Drug Discovery and Development
5.3.3 Precision Medicine
5.3.4 Others
5.4 By End User
5.4.1 Hospitals & Clinics
5.4.2 Research Centers
5.4.3 Pharmaceutical and Biotechnology Companies
5.4.4 Others
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle-East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle-East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Illumina, Inc.
6.1.2 Thermo Fisher Scientific
6.1.3 Agilent Technologies
6.1.4 Luminex Corporation
6.1.5 Myriad Genetics, Inc.
6.1.6 Perkinelmer Inc.
6.1.7 GE Healthcare
6.1.8 F. Hoffmann-La Roche Ltd.
6.1.9 Pacific Biosciences of California, Inc.
6.1.10 QIAGEN


7 MARKET OPPORTUNITIES AND FUTURE TRENDS